APA (7th ed.) Citation

PV, M., L, C., S, I., L, D. M., DO, F., A, R., . . . V, O. (2026). Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence. Current allergy and asthma reports, 26(1), . https://doi.org/10.1007/s11882-026-01271-8

Chicago Style (17th ed.) Citation

PV, Mari, et al. "Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence." Current Allergy and Asthma Reports 26, no. 1 (2026). https://doi.org/10.1007/s11882-026-01271-8.

MLA (9th ed.) Citation

PV, Mari, et al. "Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence." Current Allergy and Asthma Reports, vol. 26, no. 1, 2026, https://doi.org/10.1007/s11882-026-01271-8.